AEHRTechnology · Semiconductor Equipment & MaterialsThe 6 Wall Street analysts covering Aehr Test Systems hold a median 12-month price target of $120 — +67.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 11 of 100 as at 13 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Aehr Test Systems on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (80): The shares have been drifting up relative to others.
Volatility (1): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on AEHR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +67.9% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 10 Sept 2026 | Oppenheimer | Initiates | Outperform | $120 |
| 14 Aug 2026 | Jefferies | Initiates | Buy | $175 |
| 14 Aug 2026 | Jefferies | Initiates | Buy | — |
| 5 Mar 2026 | Freedom Broker | Maintains | Hold | — |
| 5 Mar 2026 | Freedom Broker | Maintains | Hold | $24 → $38 |
| 2 Mar 2026 | William Blair | Upgrade | Outperform | — |
| 2 Mar 2026 | William Blair | Upgrade | Outperform | — |
| 13 Feb 2026 | Freedom Broker | Maintains | Hold | — |
| 13 Jan 2026 | Freedom Broker | Maintains | Hold | — |
| 9 Jan 2026 | Craig-Hallum | Maintains | Hold | — |
| 17 Dec 2025 | Lake Street | Initiates | Buy | — |
| 14 Oct 2025 | Freedom Broker | Maintains | Hold | — |
| 26 Mar 2024 | Craig-Hallum | Downgrade | Hold | — |
| 25 Mar 2024 | William Blair | Downgrade | Market Perform | — |
| 17 Oct 2022 | William Blair | Initiates | Outperform | — |
| 10 Oct 2016 | Craig-Hallum | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AEHR appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Aehr Test Systems returned +162.0% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 37% of US stocks
Cheaper than 5% of US stocks
Cheaper than 8% of US stocks
Cheaper than 98% of US stocks
Higher than 79% of US stocks
Higher than 67% of US stocks
Higher than 53% of US stocks
Higher than 26% of US stocks
Higher than 17% of US stocks
Higher than 40% of US stocks
Higher than 33% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Aehr Test Systems has a market value of $2.5B and an enterprise value of $2.4B.
Revenue in the twelve months to 31 May 2026: $50.0M. The latest quarter grew 33.7% year on year.
Net income over the same four quarters: −$7.1M, a −14.3% net margin.
Diluted earnings per share, trailing twelve months: $−0.24.
Free cash flow in the twelve months to 31 May 2026: −$5.4M.
Trailing P/E: 19.8×; forward P/E: 56.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Aehr Test Systems employs 138 people — $362K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Aehr Test Systems — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research reports that implied volatility in Aehr Test Systems (AEHR) stock options has been surging, citing recent movements in the options market.
Why it matters — AEHR watchers may find the recent options-market activity relevant when following the stock.
Aehr Test Systems said it will report first-quarter fiscal 2027 financial results, for the quarter ended September 25, 2026, after market close on November 2, 2026. The company also announced a conference call and webcast at 5:00 p.m.
Why it matters — AEHR watchers can note the date and time when the company plans to share quarterly results and discuss them.
Aehr Test Systems announced approximately $6 million in follow-on production orders from its lead hyperscale customer for package-level burn-in of the customer's next-generation AI processor. The orders cover additional Sonoma systems, turnkey burn-in modules, device-specific sockets, and software enhancements; production is expected to ramp in calendar 2027.
Why it matters — The orders support the customer's second AI processor program on Sonoma and indicate further production deployment of Aehr's package-level burn-in systems.
Zacks compares Aehr Test Systems with Camtek as semiconductor equipment investments, citing Aehr's AI-driven burn-in demand, record backlog, and sharp fiscal 2027 growth outlook as strengthening its case despite a richer valuation.
Why it matters — Aehr watchers would care because the piece highlights the company's AI-related demand and record order backlog as competitive advantages in the semiconductor equipment space.
A Zacks Investment Research report highlights that Aehr Test Systems (AEHR) has the two key ingredients for a likely earnings beat in its upcoming report, and notes that earnings are expected to grow. The piece aims to prepare investors with key expectations for the release.
Why it matters — An AEHR watcher would care because the report points to a possible positive earnings outcome and growth expectations ahead of the company's upcoming results.
The 6 Wall Street analysts covering Aehr Test Systems have a median 12-month price target of $120, with estimates ranging from $110 to $175. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering Aehr Test Systems, 6 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Aehr Test Systems 11 out of 100 across roughly 4,600 US stocks as at 13 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Oct 2026, Aehr Test Systems ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (80 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +67.9% from the last close, and Ticker Nerd's factor model ranks Aehr Test Systems 11 out of 100 as at 13 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Aehr Test Systems publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AEHR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $110 to $175 over the next 12 months.
Aehr Test Systems returned +162.0% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Aehr Test Systems, Inc. is a semiconductor test and burn-in equipment company that develops and markets solutions for validating the reliability of integrated circuits and related devices.
The most recent item we track (Zacks Investment Research, 13 Oct 2026): "Implied Volatility Surging for Aehr Stock Options". Zacks Investment Research reports that implied volatility in Aehr Test Systems (AEHR) stock options has been surging, citing recent movements in the options market.
Aehr Test Systems, Inc. is a semiconductor test and burn-in equipment company that develops and markets solutions for validating the reliability of integrated circuits and related devices. Aehr Test Systems focuses on wafer-level, singulated die, and package-level testing for applications across power semiconductors, memory, logic, optical, and sensor devices. Its product portfolio includes full-wafer test and burn-in systems, contactors, carriers, aligners, and related support equipment used by semiconductor manufacturers to screen devices before they enter production use. The company serves customers across major technology regions, including North America, Asia, Europe, and the Middle East, and operates as a specialized supplier within the semiconductor capital equipment market. Aehr Test Systems is headquartered in Fremont, California.
CEO Mr. Gayn Erickson · 138 employees · United States · https://www.aehr.com
